Clinical Pharmacokinetics of Upadacitinib: Review of Data Relevant to the Rheumatoid Arthritis Indication.

Clin Pharmacokinet · 2020 · PMC7217812 · PMID 31867699

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Total bodyweight was a significant covariate on the upadacitinib Vc/F but did not reach statistical significance for the apparent oral clearance (CL/F) in this analysis.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.